Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORPHEUS URANIUM LIMITED M&A Activity 2026

Apr 26, 2026

65509_rns_2026-04-26_edcdab85-3e3d-4b88-97b5-c1abe3362024.pdf

M&A Activity

Open in viewer

Opens in your device viewer

ORPHEUS
URANIUM LTD
ASX RELEASE I 27 APRIL 2026
ASX: ORP

Oobagooma Acquisition Update

Orpheus Uranium Limited (ASX:ORP) (“Orpheus” or “the Company”) refers to the acquisition of the Oobagooma Uranium Project from Jackson Cage Pty Ltd (a wholly-owned subsidiary of Elevate Uranium Limited) (Oobagooma Acquisition).

Orpheus advises that the date by which the Oobagooma Acquisition is required to complete has been extended to 22 July 2026 in order to finalise certain conditions precedent to completion of the transaction relating to the entry into third party agreements (refer ASX announcement of 14 October 2025 for further details).

Orpheus remains focused on delivering the strategic Oobagooma Acquisition and looks forward to working with Jackson Cage Pty Ltd and the relevant third parties to finalise the arrangements.

Orpheus will advise the market when the conditions to completion of the Oobagooma Acquisition have been satisfied.

-END-

This announcement was approved for release by the Board of Orpheus Uranium Limited.

ASX: ORP | Orpheus Uranium Limited
ABN 97 008 084 848
79 King William Road, Unley,
South Australia 5061
orpheusuranium.com
[email protected]
+61 8 8231 0381


ASX: ORP

ORPHEUS

URANIUM LTD

For further information, please contact:

Clinton Dubieniecki
Managing Director & Chief Executive Officer
E. [email protected]

Richard Willson
Company Secretary
E. [email protected]

About Orpheus Uranium

Orpheus Uranium Limited is an Australian Securities Exchange (ASX) listed exploration company exploring for uranium in South Australia and the Northern Territory, both jurisdictions which allow uranium exploration, mining and processing. More recently, Orpheus has extended tenure into Western Australia, through the acquisition of the Oobagooma Uranium Project (progressing sale agreement through to completion), a state that contains multiple known uranium deposits.

Forward Looking Statements

The written presentation may contain forward-looking statement regarding the outlook for the Company's interpretation, work programs, and financial results. These forward-looking statements generally can be identified by phrases such as "anticipates", "potential", "plans", "intends", "believes", "likely", "appears", "expects", "likely", "appears" or other words or phrases of similar impact. There is inherent risk and uncertainty in any forward-looking statements. Variance will occur and some could be materially different from management's opinion. Developments that could impact the Company's expectations include a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those expressed or implied, including, without limitation, business integration risks; uncertainty of development plans and cost estimates, commodity price fluctuations; political or economic instability and regulatory changes; currency fluctuations, the state of the capital markets, Orpheus' ability to attract and retain qualified personnel and management, potential labour unrest, unpredictable risks and hazards related to the development and operation of exploration programs that are beyond the Company's control, the availability of capital to fund all of the Company's projects. These forward-looking statements are made as of the date of this presentation and the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements, except in accordance with applicable securities laws.

ASX: ORP | Orpheus Uranium Limited

ABN 97 008 084 848

79 King William Road, Unley,

South Australia 5061

orpheusuranium.com

[email protected]

+61 8 8231 0381